1 January 2014 in Journal of Cell Science
Nuclear lamins form the major structural elements comprising the nuclear lamina. While loss of nuclear structural integrity has been implicated as a key factor in the lamin A gene mutations causing laminopathies, the normal regulation of lamin A/C (LA/C) assembly and organization in interphase cells is still undefined. We assumed phosphorylation to be a major determinant, identifying 21 prime interphase phosphorylation sites, with 8 high turnover sites. The roles of these latter sites were examined by site-directed mutagenesis, followed by detailed microscopic analysis, including fluorescence recovery after photobleaching, fluorescence correlation spectroscopy, and nuclear extraction techniques. Results reveal three phosphorylation regions, each with dominant sites, together controlling LA/C structure and dynamics. Interestingly, two of these interphase sites are hyperphosphorylated in mitotic cells and one is within the sequence missing in progerin of the Hutchinson Gilford Progeria Syndrome. A model is presented where different phosphorylation combinations will yield markedly different effects on the assembly, subunit turnover, and mobility of LA/C between and within the lamina, the nucleoplasm, and the cytoplasm of interphase cells.
31 May 2015 in Cancer Research
Epithelial–mesenchymal transition (EMT) in cells is a developmental process adopted during tumorigenesis that promotes metastatic capacity. In this study, we advance understanding of EMT control in cancer cells with the description of a novel vimentin–ERK axis that regulates the transcriptional activity of Slug (SNAI2). Vimentin, ERK, and Slug exhibited overlapping subcellular localization in clinical specimens of triple-negative breast carcinoma. RNAi-mediated ablation of these gene products inhibited cancer cell migration and cell invasion through a laminin-rich matrix. Biochemical analyses demonstrated direct interaction of vimentin and ERK, which promoted ERK activation and enhanced vimentin transcription. Consistent with its role as an intermediate filament, vimentin acted as a scaffold to recruit Slug to ERK and promote Slug phosphorylation at serine-87. Site-directed mutagenesis established a requirement for ERK-mediated Slug phosphorylation in EMT initiation. Together, these findings identified a pivotal step in controlling the ability of Slug to organize hallmarks of EMT. Cancer Res; 75(11); 2349–62. ©2015 AACR.
1 May 2011 in Journal of Cell Science
Intermediate filament (IF) proteins comprise a large family with more than 70 members. Initially, IFs were assumed to provide only structural reinforcement for the cell. However, IFs are now known to be dynamic structures that are involved in a wide range of cellular processes during all stages of life, from development to ageing, and during homeostasis and stress. This Commentary discusses some lesser-known functional and regulatory aspects of IFs. We specifically address the emerging roles of nestin in myogenesis and cancer cell migration, and examine exciting evidence on the regulation of nestin and lamin A by the notch signalling pathway, which could have repercussions for our understanding of the roles of IF proteins in development and ageing. In addition, we discuss the modulation of the post-translational modifications of neuronally expressed IFs and their protein–protein interactions, as well as IF glycosylation, which not only has a role in stress and ageing, but might also regulate IFs during development. Although many of these recent findings are still preliminary, they nevertheless open new doors to explore the functionality of the IF family of proteins.
23 November 2009 in Oncogene
1 May 2011 in Molecular Biology of the Cell
Many types of progenitor cells are distinguished by the expression of the intermediate filament protein nestin, a frequently used stem cell marker, the physiological roles of which are still unknown. Whereas myogenesis is characterized by dynamically regulated nestin levels, we studied how altering nestin levels affects myoblast differentiation. Nestin determined both the onset and pace of differentiation. Whereas depletion of nestin by RNAi strikingly accelerated the process, overexpression of nestin completely inhibited differentiation. Nestin down-regulation augmented the early stages of differentiation, at the level of cell-cycle withdrawal and expression of myogenic markers, but did not affect proliferation of undifferentiated dividing myoblasts. Nestin regulated the cleavage of the Cdk5 activator protein p35 to its degradation-resistant form, p25. In this way, nestin has the capacity to halt myoblast differentiation by inhibiting sustained activation of Cdk5 by p25, which is critical for the progress of differentiation. Our results imply that nestin regulates the early stages of myogenesis rather than maintains the undifferentiated state of progenitor cells. In the bidirectional interrelationship between nestin and Cdk5, Cdk5 regulates the organization and stability of its own nestin scaffold, which in turn controls the effects of Cdk5. This nestin–Cdk5 cross-talk sets the pace of muscle differentiation.